2009 Publications
Total of 43
1. A genome-wide association study reveals variants in ARL15 that influence adiponectin
levels.
Richards JB, Waterworth D, O'Rahilly S, Hivert MF, Loos RJ, Perry JR, Tanaka T,
Timpson NJ, Semple RK, Soranzo N, Song K, Rocha N, Grundberg E, Dupuis J, Florez
JC, Langenberg C, Prokopenko I, Saxena R, Sladek R, Aulchenko Y, Evans D, Waeber
G, Erdmann J, Burnett MS, Sattar N, Devaney J, Willenborg C, Hingorani A, Witteman
JC, Vollenweider P, Glaser B, Hengstenberg C, Ferrucci L, Melzer D, Stark K,
Deanfield J, Winogradow J, Grassl M, Hall AS, Egan JM, Thompson JR, Ricketts SL,
König IR, Reinhard W, Grundy S, Wichmann HE, Barter P, Mahley R, Kesaniemi YA,
Rader DJ, Reilly MP, Epstein SE, Stewart AF, Van Duijn CM, Schunkert H, Burling K,
Deloukas P, Pastinen T, Samani NJ, McPherson R, Davey Smith G, Frayling TM,
Wareham NJ, Meigs JB, Mooser V, Spector TD; GIANT Consortium.
PLoS Genet. 2009 Dec;5(12):e1000768. Epub .PMID: 20011104 [PubMed - in
process]Related articlesFree article
2. Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and
Simvastatin.
Lakoski SG, Xu F, Vega GL, Grundy SM, Chandalia M, Lam C, Lowe RS, Stepanavage
ME, Musliner TA, Cohen JC, Hobbs HH.
J Clin Endocrinol Metab. 2009 Dec 4. [Epub ahead of print]PMID: 19965915 [PubMed
- as supplied by publisher]Related articles
3. Harmonizing the metabolic syndrome: a joint interim statement of the International
Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung,
and Blood Institute; American Heart Association; World Heart Federation; International
Atherosclerosis Society; and International Association for the Study of Obesity.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC,
James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on
Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American
Heart Association; World Heart Federation; International Atherosclerosis Society;
International Association for the Study of Obesity.
Circulation. 2009 Oct 20;120(16):1640-5. Epub 2009 Oct 5.PMID: 19805654 [PubMed
- indexed for MEDLINE]Related articles
4. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein
cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients
with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
Am J Cardiol. 2009 Aug 15;104(4):548-53.PMID: 19660610 [PubMed - indexed for
MEDLINE]Related articles
1
5. Plasma triglycerides and cardiovascular events in the Treating to New Targets and
Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins
in patients with coronary artery disease.
Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC,
Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR; Steering
Committees of IDEAL and TNT Trials.
Am J Cardiol. 2009 Aug 15;104(4):459-63. Epub 2009 Jun 24.PMID: 19660594
[PubMed - indexed for MEDLINE]Related articles
6. Sex differences in the relationship between C-reactive protein and body fat.
Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA.
J Clin Endocrinol Metab. 2009 Sep;94(9):3251-8. Epub 2009 Jun 30.PMID: 19567538
[PubMed - indexed for MEDLINE]Related articles
7. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity
and fat distribution.
Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L, Speliotes EK,
Thorleifsson G, Willer CJ, Herrera BM, Jackson AU, Lim N, Scheet P, Soranzo N,
Amin N, Aulchenko YS, Chambers JC, Drong A, Luan J, Lyon HN, Rivadeneira F,
Sanna S, Timpson NJ, Zillikens MC, Zhao JH, Almgren P, Bandinelli S, Bennett AJ,
Bergman RN, Bonnycastle LL, Bumpstead SJ, Chanock SJ, Cherkas L, Chines P, Coin
L, Cooper C, Crawford G, Doering A, Dominiczak A, Doney AS, Ebrahim S, Elliott P,
Erdos MR, Estrada K, Ferrucci L, Fischer G, Forouhi NG, Gieger C, Grallert H, Groves
CJ, Grundy S, Guiducci C, Hadley D, Hamsten A, Havulinna AS, Hofman A, Holle R,
Holloway JW, Illig T, Isomaa B, Jacobs LC, Jameson K, Jousilahti P, Karpe F, Kuusisto
J, Laitinen J, Lathrop GM, Lawlor DA, Mangino M, McArdle WL, Meitinger T, Morken
MA, Morris AP, Munroe P, Narisu N, Nordström A, Nordström P, Oostra BA, Palmer
CN, Payne F, Peden JF, Prokopenko I, Renström F, Ruokonen A, Salomaa V, Sandhu
MS, Scott LJ, Scuteri A, Silander K, Song K, Yuan X, Stringham HM, Swift AJ, Tuomi
T, Uda M, Vollenweider P, Waeber G, Wallace C, Walters GB, Weedon MN; Wellcome
Trust Case Control Consortium, Witteman JC, Zhang C, Zhang W, Caulfield MJ,
Collins FS, Davey Smith G, Day IN, Franks PW, Hattersley AT, Hu FB, Jarvelin MR,
Kong A, Kooner JS, Laakso M, Lakatta E, Mooser V, Morris AD, Peltonen L, Samani
NJ, Spector TD, Strachan DP, Tanaka T, Tuomilehto J, Uitterlinden AG, van Duijn CM,
Wareham NJ, Hugh Watkins; Procardis Consortia, Waterworth DM, Boehnke M,
Deloukas P, Groop L, Hunter DJ, Thorsteinsdottir U, Schlessinger D, Wichmann HE,
Frayling TM, Abecasis GR, Hirschhorn JN, Loos RJ, Stefansson K, Mohlke KL,
Barroso I, McCarthy MI; Giant Consortium.
PLoS Genet. 2009 Jun;5(6):e1000508. Epub 2009 Jun 26. Erratum in: PLoS Genet. 2009
Jul;5(7). doi: 10.1371/annotation/b6e8f9f6-2496-4a40-b0e3-e1d1390c1928. PMID:
19557161 [PubMed - indexed for MEDLINE]Related articlesFree article
2
8. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients
with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB,
Adewale AJ, Polis AB, Tomassini JE, Tershakovec AM.
Am J Cardiol. 2009 Jun 15;103(12):1694-702.PMID: 19539078 [PubMed - indexed for
MEDLINE]Related articles
9. Evaluation of coronary artery calcium screening strategies focused on risk categories:
the Dallas Heart Study.
Patel MJ, de Lemos JA, McGuire DK, See R, Lindsey JB, Murphy SA, Grundy SM,
Khera A.
Am Heart J. 2009 Jun;157(6):1001-9.PMID: 19464410 [PubMed - indexed for
MEDLINE]Related articles
10. Impaired hepatic ketogenesis in moderately obese men with hypertriglyceridemia.
Vega GL, Dunn FL, Grundy SM.
J Investig Med. 2009 Apr;57(4):590-4.PMID: 19342925 [PubMed - indexed for
MEDLINE]Related articles
11. Effect of a high-fiber diet compared with a moderate-fiber diet on calcium and other
mineral balances in subjects with type 2 diabetes.
Shah M, Chandalia M, Adams-Huet B, Brinkley LJ, Sakhaee K, Grundy SM, Garg A.
Diabetes Care. 2009 Jun;32(6):990-5. Epub 2009 Mar 11.PMID: 19279300 [PubMed indexed for MEDLINE]Related articlesFree article
12. Genome-wide linkage and association analyses to identify genes influencing adiponectin
levels: the GEMS Study.
Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, Mahley
RW, McPherson R, Waeber G, Bersot TP, Cohen JC, Grundy SM, Mooser VE, Mitchell
BD.
Obesity (Silver Spring). 2009 Apr;17(4):737-44. Epub 2009 Jan 22.PMID: 19165155
[PubMed - indexed for MEDLINE]Related articles
13. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines:
emerging biomarkers for primary prevention of cardiovascular disease.
NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M,
Ballantyne CM, Cooper GR, Pfeiffer CM, Grundy SM, Labarthe DR, Levy D, Rifai N,
Wilson PW.
Clin Chem. 2009 Feb;55(2):378-84. Epub 2008 Dec 23.PMID: 19106185 [PubMed indexed for MEDLINE]Related articles
14. Ethnic differences in hepatic steatosis: an insulin resistance paradox?
Guerrero R, Vega GL, Grundy SM, Browning JD.
Hepatology. 2009 Mar;49(3):791-801.PMID: 19105205 [PubMed - indexed for
MEDLINE]Related articles
3
15. Low-density lipoprotein cholesterol reduction and goal achievement with
ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes,
metabolic syndrome, or neither disease, stratified by National Cholesterol Education
Program risk category.
Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS,
Tershakovec AM.
Metab Syndr Relat Disord. 2009 Dec;7(6):601-10.PMID: 19929597 [PubMed - in
process]Related articles
16. GRB10 gene and type 2 diabetes in Whites.
Di Paola R, Wojcik J, Succurro E, Marucci A, Chandalia M, Padovano L, Powers C,
Merla G, Abate N, Sesti G, Doria A, Trischitta V.
J Intern Med. 2010 Jan;267(1):132-3. Epub 2009 Oct 9. No abstract available. PMID:
19818100 [PubMed - in process]Related articles
17. IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult
ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk'
variants.
Morini E, Prudente S, Succurro E, Chandalia M, Zhang YY, Mammarella S, Pellegrini
F, Powers C, Proto V, Dallapiccola B, Cama A, Sesti G, Abate N, Doria A, Trischitta V.
Diabetologia. 2009 Sep;52(9):1852-7. Epub 2009 Jun 26.PMID: 19557384 [PubMed indexed for MEDLINE]Related articles
18. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI.
Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P,
Chua S, Scherer PE.
Mol Cell Biol. 2009 Mar;29(6):1575-91. Epub 2008 Dec 29.PMID: 19114551 [PubMed
- indexed for MEDLINE]Related articlesFree article
19. The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes.
Prudente S, Scarpelli D, Chandalia M, Zhang YY, Morini E, Del Guerra S, Perticone F,
Li R, Powers C, Andreozzi F, Marchetti P, Dallapiccola B, Abate N, Doria A, Sesti G,
Trischitta V.
J Clin Endocrinol Metab. 2009 Jan;94(1):190-6. Epub 2008 Nov 4.PMID: 18984671
[PubMed - indexed for MEDLINE]Related articlesFree article
20. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous
nonsense mutation in CIDEC.
Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, Hyden CS,
Bottomley W, Vigouroux C, Magré J, Raymond-Barker P, Murgatroyd PR, Chawla A,
Skepper JN, Chatterjee VK, Suliman S, Patch AM, Agarwal AK, Garg A, Barroso I,
Cinti S, Czech MP, Argente J, O'Rahilly S, Savage DB; LD Screening Consortium.
EMBO Mol Med. 2009 Aug;1(5):280-7.PMID: 20049731 [PubMed - in process]Related
articles
4
21. Choledochal cyst with large stone cast and portal hypertension.
Singh S, Kheria LS, Puri S, Puri AS, Agarwal AK.
Hepatobiliary Pancreat Dis Int. 2009 Dec;8(6):647-9.PMID: 20007085 [PubMed - in
process]Related articlesFree article
22. Atypical progeroid syndrome due to heterozygous missense LMNA mutations.
Garg A, Subramanyam L, Agarwal AK, Simha V, Levine B, D'Apice MR, Novelli G,
Crow Y.
J Clin Endocrinol Metab. 2009 Dec;94(12):4971-83. Epub 2009 Oct 29.PMID:
19875478 [PubMed - indexed for MEDLINE]Related articles
23. Terlipressin in control of acute hemobilia during therapeutic ERCP in patient with portal
biliopathy.
Tyagi P, Sachdeva S, Agarwal AK, Puri AS.
Surg Laparosc Endosc Percutan Tech. 2009 Oct;19(5):e198-201.PMID: 19851252
[PubMed - in process]Related articles
24. Pseudocyst of ectopic pancreas of the duodenal wall masquerading as malignant cystic
tumor of pancreas.
Sharma DK, Agarwal S, Saran RK, Agarwal AK.
Saudi J Gastroenterol. 2009 Oct-Dec;15(4):271-3.PMID: 19794276 [PubMed - in
process]Related articlesFree article
25. Gallbladder cancer: the role of laparoscopy and radical resection.
Singh S, Agarwal AK.
Ann Surg. 2009 Sep;250(3):494-5; author reply 495. No abstract available. PMID:
19730180 [PubMed - indexed for MEDLINE]Related articles
26. Central vein stenosis: current concepts.
Agarwal AK.
Adv Chronic Kidney Dis. 2009 Sep;16(5):360-70. Review.PMID: 19695504 [PubMed indexed for MEDLINE]Related articles
27. Anemia after intensive care unit stay: more questions than answers.
Agarwal AK.
Crit Care Med. 2009 Jun;37(6):2108-9. No abstract available. PMID: 19448458
[PubMed - indexed for MEDLINE]Related articles
28. Functional characterization of the human 1-acylglycerol-3-phosphate-O-acyltransferase
isoform 10/glycerol-3-phosphate acyltransferase isoform 3.
Sukumaran S, Barnes RI, Garg A, Agarwal AK.
J Mol Endocrinol. 2009 Jun;42(6):469-78. Epub 2009 Mar 24.PMID: 19318427
[PubMed - indexed for MEDLINE]Related articles
5
29. Drug safety profile of darbepoetin alfa for anemia of chronic kidney disease.
Agarwal AK.
Expert Opin Drug Saf. 2009 Mar;8(2):145-53. Review.PMID: 19309243 [PubMed indexed for MEDLINE]Related articles
30. Melanocortin-4-receptor autoantibodies: a new player in obesity.
Mohan C, Agarwal AK.
J Clin Endocrinol Metab. 2009 Mar;94(3):757-9. No abstract available. PMID:
19261898 [PubMed - indexed for MEDLINE]Related articles
31. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2deficient mouse model of congenital generalized lipodystrophy.
Cortés VA, Curtis DE, Sukumaran S, Shao X, Parameswara V, Rashid S, Smith AR,
Ren J, Esser V, Hammer RE, Agarwal AK, Horton JD, Garg A.
Cell Metab. 2009 Feb;9(2):165-76.PMID: 19187773 [PubMed - indexed for
MEDLINE]Related articles
32. Lipodystrophies: disorders of adipose tissue biology.
Garg A, Agarwal AK.
Biochim Biophys Acta. 2009 Jun;1791(6):507-13. Epub 2009 Jan 7. Review.PMID:
19162222 [PubMed - indexed for MEDLINE]Related articles
33. A sequence variation (I148M) in PNPlA3 associated with nonalcoholic fatty liver
disease disrupts triglyceride hydrolysis.
He S, McPhaul C, Li JZ, Garuti R, Kinch LN, Grishin NV, Cohen JC, Hobbs HH.
J Biol Chem. 2009 Dec 23. [Epub ahead of print]PMID: 20034933 [PubMed - as
supplied by publisher]Related articlesFree article
34. Genetic and metabolic determinants of plasma PCSK9 levels.
Lakoski SG, Lagace TA, Cohen JC, Horton JD, Hobbs HH.
J Clin Endocrinol Metab. 2009 Jul;94(7):2537-43. Epub 2009 Apr 7.PMID: 19351729
[PubMed - indexed for MEDLINE]Related articles
35. Genetic variation in ANGPTL4 provides insights into protein processing and function.
Yin W, Romeo S, Chang S, Grishin NV, Hobbs HH, Cohen JC.
J Biol Chem. 2009 May 8;284(19):13213-22. Epub 2009 Mar 7.PMID: 19270337
[PubMed - indexed for MEDLINE]Related articlesFree article
36. Rare loss-of-function mutations in ANGPTL family members contribute to plasma
triglyceride levels in humans.
Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC.
J Clin Invest. 2009 Jan;119(1):70-9. doi: 10.1172/JCI37118. Epub 2008 Dec 15.PMID:
19075393 [PubMed - indexed for MEDLINE]Related articlesFree article
6
37. PCSK9: a convertase that coordinates LDL catabolism.
Horton JD, Cohen JC, Hobbs HH.
J Lipid Res. 2009 Apr;50 Suppl:S172-7. Epub 2008 Nov 19.PMID: 19020338 [PubMed
- indexed for MEDLINE]Related articles
38. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and
cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.
Subramanyam L, Simha V, Garg A.
Clin Genet. 2009 Dec 22. [Epub ahead of print]PMID: 20041886 [PubMed - as supplied
by publisher]Related articles
39. Inherited lipodystrophies and hypertriglyceridemia.
Simha V, Garg A.
Curr Opin Lipidol. 2009 Aug;20(4):300-8. Review.PMID: 19494770 [PubMed - indexed
for MEDLINE]Related articles
40. Atf4 regulates obesity, glucose homeostasis, and energy expenditure.
Seo J, Fortuno ES 3rd, Suh JM, Stenesen D, Tang W, Parks EJ, Adams CM, Townes T,
Graff JM.
Diabetes. 2009 Nov;58(11):2565-73. Epub 2009 Aug 18.PMID: 19690063 [PubMed indexed for MEDLINE]Related articles
41. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological
activation of the liver X receptor in mice.
Grefhorst A, Parks EJ.
J Lipid Res. 2009 Jul;50(7):1374-83. Epub 2009 Mar 14.PMID: 19287042 [PubMed indexed for MEDLINE]Related articles
42. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal
angiotensin-converting enzyme inhibition in diabetic nephropathy.
Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD.
J Am Soc Nephrol. 2009 Dec;20(12):2641-50. Epub 2009 Nov 19.PMID: 19926893
[PubMed - indexed for MEDLINE]Related articles
43. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of
childhood acute lymphoblastic leukemia.
Oeffinger KC, Adams-Huet B, Victor RG, Church TS, Snell PG, Dunn AL, EshelmanKent DA, Ross R, Janiszewski PM, Turoff AJ, Brooks S, Vega GL.
J Clin Oncol. 2009 Aug 1;27(22):3698-704. Epub 2009 Jun 29.PMID: 19564534
[PubMed - indexed for MEDLINE]Related articles
7